Sigachi Industries Limited has informed the Exchange about Investor Presentation

Years SIGACHIINDUSTRIESLIMITED CIN: L24110TG1989PLC009497 ANEXCiPACTGMP,ISO9001:2015&FSSC22000CERTIFIEDCOMPANY www.sigachi.com To, Date: 19.08.2023 The Manager BSE Limited P.J. Towers, Dalal Street Mumbai- 400001 (BSE Scrip Code: 543389) The Manager National Stock Exchange of India Limited Exchange Plaza, BandraKurla Complex, Bandra (E), Mumbai- 400051 (NSE Symbol: SIGACHI) Dear Sir/ Madam, Unit: Sigachi Industries Limited Sub: Investor Presentation **** Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) 2015, and with reference to the subject cited, please find enclosed the Investor Presentation. The same is also uploaded on the website of the Company www.sigachi.com. This is for your information and records. Thanking you. Yours sincerely For Sigachi Industries Limited Shreya Mitra Company Secretary and Compliance Officer Encl. Sigachi Industries LimitedInvestor PresentationAugust -2023SigachiIndustries Limited2Company SnapshotSupported by Experienced Management TeamLegacy of more than 3 decades in manufacturing of cellulose-based excipient Long standing Pan India presence & Exports to more than 50 countries4 state-of-the-art manufacturing facilities situated in Hyderabad and GujaratR&D Facility inDahej isapproved byDSIR and alsohave other 2 in-houselaboratories3 year CAGRRevenue: 29.49% EBITDA: 33.27%PAT: 29.02%Company OverviewSigachiIndustries LimitedCompany Overview4•Sigachi Industries Limited (Sigachi), incorporated in the year 1989, is one of the leading manufacturers of MicroCrystallineCellulose(MCC) in the world.•Sigachi manufactures high-quality cellulose-based excipients, which predominantly find usage in the pharmaceutical, supplement and food industries.•The company has created a niche in manufacturing highly innovative pre-formulated excipients & 60+ widely used excipients of international quality standards.•With two facilities in Gujarat and two in Telangana, Sigachi ensures supply chain reliability for its customers in India and across the globe.•Sigachi has a global sales and distribution network and exports to more than 50 countries across Asia, Australia, American Continent, Europe and Middle East.•From its state-of-the-art R & D facility the company ensures continuous innovation to efficiently meet evolving customer demands.•The company has an agreement with Gujarat Alkalies and Chemicals Limited (“GACL”) and also with Grasim Industries(Aditya Birla Group) for operating and managing the manufacturing units owned by GACL and for contract manufacturing of sodium chlorate, stable bleaching powder and poly aluminum chloride.1,9282,5033,02084720.12%21.21%19.43%19.36%FY21FY22FY23Q1-FY24Revenue (INR Mn) & EBITDA Margins (%) SigachiIndustries LimitedKey Management Personnel5Mr. R P SinhaFounder, Chairperson,Whole-Time Director•Holds Master’s degree in Chemical Engineering from Banaras Hindu University•He has over 3 decades of experience in the cellulose and fine chemicals industry•Has played an instrumental role in setting up of the wholly owned Subsidiary, Sigachi US Inc. and in expansion of our export operationsMr. Amit Raj SinhaMD & CEO•He has an MBA from Indian School of Business, B. Tech & fellow member of the Institute of Engineers•Served in Indian naval forces onboard warships & other vital defence installations.•Has over 20 years of experience in the pharma and fine chemicals & has played an instrumental role in strengthening the R&D Division.Mr. ChidambarnathanShanmuganathanCo-Founder, Whole-Time Director•Holds PG Diploma in business administration from Annamalai University•Has over 5 decades of experience in the field of chemicals & derivatives of cellulose •Has played an instrumental role in expanding the domestic operation & in setting up of manufacturing units in GujaratMr. OS ReddyChief Financial Officer•He is a Chartered Accountant by profession and an MBA from Sikkim Manipal University •Over 30 years of industry experience & over 20 years in pharmaceuticals and chemicals•Overall, in-charge of the finance, accounts and compliance functionsSigachiIndustries LimitedKey Milestones6Incorporated as ‘Sigachi Chloro-Chemicals Private Limited’ with the business to manufacture paraffin oil198919901996199820002008200920122014200620072010201120162020Diversified to manufacture microcrystalline (MCC) celluloseBegan in-house manufacturing of alpha celluloseCommenced its export operations by exporting its product, MCC to BangkokStarted manufacturing of premium grade MCC by commissioning a spray drier and a multi-fuel furnace, which increased capacity from 720 to 1080 MTPAR&D laboratory received an accreditation from Department of Science and Industrial Research to undertake R&DRegistered its Drug Master File (“DMF”) for the first time under the US FDA enabling to augment the export operationsSet up a unit for manufacturing MCC at Jhagadia,Setting up of 100 % export-oriented unit (“EOU”) for manufacturing MCC in the SEZ at Dahej, Gujarat.Commenced the commercial production of MCC at manufacturing unit situated at JhagadiaThe R&D division innovated a novel filtration process for manufacturing MCCCommenced the commercial production of MCC at the manufacturing unit situated at DahejMerger of Sigachi Cellulose Private Limited and Sigachi Plasticizers Private Limited with the companyReceived ISO 9001:2008 certificate for the management system situated at JhagadiaReceived ISO 9001:2015 for all manufacturing units2021Got listed on NSE & BSE on Nov 15, 2021SigachiIndustries LimitedGlobal Presence761.18%68.15%75.43%73.41%38.82%31.85%24.57%26.59%FY20FY21FY22FY23Sales MixExportDomesticMore than 2 decades of operation through exclusive distributor in ANZ marketOperating through merchant exportersStrong relationship with end customers and distributorsOperating through non-exclusive distributors having strong market presenceTrading business of MCC powder, food & pharma ingredients is operated through the subsidiary Sigachi US IncUnit 2 - Jhagadia, GujaratUnit 3 - Dahej, GujaratUnit 1 – Hyderabad, Telangana26%20%15%12%5%3%2%2%2%2%2%9%Geographical Revenue Mix % (FY23)IndiaUSAAustraliaSwedenDenmarkEgyptChinaSpainUKPolandManufacturing FacilitiesSigachiIndustries LimitedManufacturing Plants8•Sigachi has three manufacturing units namely, Hyderabad, Telangana (“Unit I”), Jhagadia, Gujarat (“Unit II”) and Dahej, Gujarat (“Unit III”).•These units help in providing timely, efficient and customized delivery of the products to domestic and international customers.•Unit II and Unit III are spread over an area of approximately 1.44 acres and 2.67 acres, respectively.•The manufacturing plant at Unit III is located in the SEZ and is entirely an export-oriented unit.•Sigachi intends to tap the growing demand of MCC by expanding the manufacturing capacities at Unit II and Unit III.Hyderabad Plant Dahej SEZ Plant Jhagadia Plant4,8002,7506,4004,6162,6585,92596.17%96.65%92.58%DahejJhagadiaHyderabadManufacturing Capacities (MTPA) & Capacity Utilisation in % (as on FY23)Installed CapacityProduction VolumeSigachiIndustries Limited9R&D and Quality Assurance R&D:•The Research and Development division is located in Jhagadia and Dahej with the objective to implement a performance-oriented approach with the help of technologies developed in-house.•R&D Division is equipped with the necessary facilities to carry out all necessary trials to develop new molecules from concept to commissioning.•R&D Division works on specific projects along with experts in their respective fields, focusing on application research to explore new grades of MCC. •Laboratory at Jhagadia has been approved and has received an accreditation from Department of Science and Industrial Research (“DSIR”).Quality Assurance:•The company has quality control and assurance division in all manufacturing units and carries out all the required tests on the materials received including raw material which are used in the manufacturing process and also on the final products. •Team of experts carries out various application tests to ascertain the true nature of the constituents and ensure the quality of our products as per the customer requirements and international standards.•Company has received various certifications for the manufacturing process, managements systems implemented and the raw materials used during the manufacture of the products.SigachiIndustries LimitedMarquee Clients10SigachiIndustries LimitedAwards and Accolades11Honored with ‘DHL SME ZEE Business Award’‘Achiever of Silver Star’ in the category of Medium Scale Industries in the HR Best Practices 2019 program’Awarded the title of ‘India’s Small Giants Emerging Enterprises of India – Roll of Honor for 2014’ by Life Insurance Corporation of IndiaAwarded the title of ‘SME Achievers of 2013’ by Bank of IndiaAwarded with the ‘National Award for Outstanding Entrepreneurship’ by the Government of IndiaBusiness OverviewSigachiIndustries LimitedAbout Microcrystalline Cellulose (MCC)13•Microcrystalline Cellulose is refined wood pulp and it is a chemically inert substance, extensively used in food, pharmaceuticals, cosmetic, and polymer composite industries.•MCC is considered as a diluent having self-binding properties and it is one of the preferred direct compressible binder owing to its dry binding properties.•It has distinguished chemical and physical properties from other excipients and duetoitschemicallyinertnatureMCCiscompatiblewithmostActivePharmaceuticalIngredients(APIs).•Goodabsorptioncapacities,broadparticlesizeprofileandgoodcompressibilitywithfastdisintegrationhasplacedtheMCCasthemostwidelyusedexcipientinthepharmaceuticalindustry.•MCC is used for the production of solid dosage form due to its good compressibility, compatibility and loading capacity of drugs. In the food industry, it is widely used as a stabilizer, anti-caking agent, fat substitute and emulsifier in food production.•It has use incosmeticsas anabrasive,absorbent, aqueousviscosityincreasing agent, binder, bulking agent, emulsion stabilizer, slip modifier, and texturizer, which can be found in various hair and skin care products as well asmakeup.•MCC is prepared by hydrolysis process at temperature, neutralized after completion of hydrolysis and then filtered and dried by spray drying or bulk drying. MCC Market Share Based on End - UseIndustryApprox%Pharmaceuticals35-40Food & Beverage20-25Cosmetics & Personal Care15-20Others10-15Source: Industry and CARE AdvisorySigachiIndustries LimitedMCC Manufacturing Process141.Sheets of wood pulp are added to glass lined reactors, for hydrolysis of the wood pulp which is carried out at the required temperature and pressure. The slurry then formed goes to the Quality Division that tests the nature and texture of the slurry.2.The slurry is then sent for filtration. At filter press, the slurry is passed through in to separate ‘mother liquor’ from the slurry and the ‘filtrate’ is sent to the effluent treatment plant. The residual cake is washed during the process to make it neutral as well as salt free. Air is passed through the cake to reduce the moisture content.3.Due to the varied applications of the products in different sectors, different drying techniques are used on the wet cakes. The various drying techniques adopted during the manufacturing process have been detailed below: a) Fluidized bed drying process (“FBD”): Basically a hot air drying process where the residual moisture is reduced to a desired level and to achieve a finer micron size it is further subjected to the pulverization process.b)SpinFlashDryer(“SFD”):The wet cake is subjected to hot air which is passed through the spin agitator, agitation speed is decided as per the particle size which has to be achieved. The powder is discharged from the cyclone through a rotary air lock valve. c)SprayDrying: The slurry is sprayed in the spray dryer where drying takes place using hot air.The product obtained from (a) and (b) are blended and sieved to make a uniform, homogeneous and a standard batch size for final packing. However, the product obtained from spray drying process is sieved and directly sent for packaging.4.The final product is packed in as specified by the customers. Once the packaging is done, the final products are then transferred to quarantine room for testing then transferred to finished goods storage area.Hydrolysis of the wood pulp sheetsFiltrationDryingPackagingSigachiIndustries LimitedWood Pulp - Key Raw Material15•The major raw material used in the manufacture of MCC is purified dissolving wood pulp bales.•These are imported from Canada, South Africa, Thailand, Indonesia and America from various suppliers.•The chemical and physical properties of the pulp determine the final quality of the finished products.•The wood pulp bales are imported based on the quality and the price at which they are available with the suppliers.•Quality Division carries out various tests such as ash content, water soluble substances, ether soluble substances, moisture content, paper brightness test, black particles etc.•Domestically sourced Hydrochloric acid and other auxiliary chemicals are also used for converting wood pulp into MCC.SigachiIndustries Limited16Sigachi in Microcrystalline Cellulose (MCC)•Sigachi is the largest manufacturers of MCC in India and one of the leading manufacturers globally, with over three decades of experience.•It manufactures MCC of 60 different grades ranging from 15 microns to 250 microns having varied applications in the pharmaceutical, food, nutraceutical and cosmetic industry.•Sigachi sells its cellulose based products under the following brands:oHiCelTMoAceCelRoCoatCelRoGloCelRoBARETabR•These products are distinguished with the help of different drying techniques during the manufacturing process.•The company produces various grades of the product in combination with various chemicals like colloidal silicon dioxide, carboxy cellulose sodium, mannitol etc. to cater to the growing market of the co-processed excipients.1,8062,2652,603729FY21FY22FY23Q1-FY24MCC Revenue Trend (INR Mn)75%20%5%Revenue Breakup (FY23)FOOD & NUTRAPHARMACOSMETICSSigachiIndustries Limited17Pharma Portfolio consists of:•Antiulcerative API’s & their intermediates•Pre-Formulated Excipients•High Functionality Excipients•Thickeners/Stabilizers•Binders•Superdisintegrants•Lubricants•Functional Fillers/Carriers•SpheresPharma Application SegmentsTabletsSpheresPowder blendsSuspensionsHealth SupplementsHard Capsule FillingSigachiIndustries Limited18Our Food Ingredients are Primarily Used as:•Stabilizer & Emulsifier•Dietary Fibre•Bulking Agent•Texturizer•Anticaking Agent•Flow ImproverFood Application SegmentsBakeryConfectioneryDairyInstant FoodSalad & SoupsBeveragesSigachiIndustries Limited19Cosmetics and Chemical Application SegmentsCosmetic Ingredients are primarily used as:•Sensory Agent•Texturizer•Filler•Humectant•Flow Enhancer•Anti-Caking AgentsMascara/EyelinerToothpasteTalcum PowderShower GelsCreams & LotionsFacial Scrubs•In the chemical sector the cellulose products are used in electrodes, and as filter aid. These products are economic and environmentally friendly.•MCC prevents cracks in welding rods, gives a good texture and produce less slag and is therefore suitable for deep penetrating welding. CHEMICAL APPLICATIONSCOSMETIC APPLICATIONSStrategic OverviewSigachiIndustries LimitedKey Strengths21One of the leading manufacturers of MCC in India with over 30 years’ experience: •Made advancements in development of MCC and positioned as one of the key manufacturing players globally •Technical capabilities, capable R&D Division and manufacturing infrastructure, gives a first mover advantage in IndiaPan India and International market presence: •A long-standing market presence in India and internationally•Exporting products to over 50 countries worldwide, including regions of US, UK, Australia, EU region, Middle East and SE Asia Comprehensive product portfolio enables to serve diverse end-use applications: •Customize the usage and application of the products to various industries including but not limited to pharmaceutical, food, nutraceuticals and cosmetics •Manufacture MCC in various grades ranging from 15 microns to 250 micronsPresence across diverse industry verticals with long standing relationship with customers :•Customization of products based on customer specifications and requirements•Track record of consistent delivery of quality and cost-effective products and solutions through strategic alignment of key customers’ goals over the yearsGrowth led by continuous investment and focus on R&D:•Regular investments in R&D to expand the product offerings and to streamline manufacturing process•2 R&D Division and 2 in-house laboratories•The laboratory in the Dahej R&D Division has been approved and has received an accreditation by DSIR to undertake R&D activitiesStrategically located manufacturing facilities •Set up 4 multi locational manufacturing units namely, Hyderabad, Sultanpur unit TG (“Unit I”), Jhagadia, Gujarat (“Unit II”) and Dahej, Gujarat (“Unit III”) and Kurnoolplant(“UnitIV”)which helps provide timely, efficient and customized delivery of the products in terms with the specific demographic needsSigachiIndustries LimitedStrategy going forward 22Increasing focus on core business segment:Pushing efforts towards manufacturing MCC and its various grades for various industries or applications leading to optimum resource utilizationDiversifying Product Mix in Pharma:Manufacturing higher grades of products as well as enhancing product basket by offering innovative new value-added productsWiden its horizon- Food & Nutrition are integral to good health:Company will venture into the human nutritional segment, with a prime focus on B2B markets, in India and across the globe. The product portfolio will include spray-dried ingredients, micronutrient premixes and other allied products.Enhancing global footprint:Increasing market share by exploring untapped marketsHealth Care Division :Capture the growing Branded Generics & OTC market and cater to the increasing health expenditure in India through launch of various products in the healthcare sectorExpanding manufacturing capacites:At Dahej and Jhagadia to focus on the growing demand of MCC, setting up a new unit at Dahej to manufacture CCS Dedicated Transformation office to oversee the Hyper growth:Enhancing customer base through marketing efforts and customizing products for various applications as per requirements of customersSigachiIndustries LimitedCapex 23•The company is expanding the production capacity of MCC by increasing the manufacturing capacity of units in Dahej and Jhagadia.•Setting up of the proposed unit for manufacturing higher grades of MCC and CCS will result in increased revenues and profitability.•The strategic decision to expand manufacturing units will increase the ability to cater to the increasing demand of its products. •The company expects to benefit from the economies of scale brought about by such increased production capacity.Manufacturing capacities at existing facilities (units in MTPA)Unit Location DahejJhagadiaHyderabadExisting Capacity (MCC)4,8002,7506,400Proposed Expansion(MCC)3,6003,600--Expected Capacity (MCC)8,4006,3506,40093243750500FY21FY22FY23FY24ECapital Expenditure (INR Mn)SigachiIndustries LimitedCroscarmellose Sodium: New Product Launch24•ThecompanyplanstoforayintotheproductionofCroscarmelloseSodium(CCS).•CCSis a modified sodium carboxymethyl cellulose used as a disintegrant in pharmaceutical formulations and provides long term stability.•It is an insoluble and hydrophilic polymer which aids in the dissolution of the dietary supplements and pharmaceutical tablets, granules, and capsules. CCS is used in various industries such as pharmaceutical, food, nutraceutical, textile, etc.•The mechanism of action of croscarmellose sodium in a tablet starts when it swells, which is highly dependent on the penetration of a liquid into the tablet.•The swelling breaks the tablet's binding forces, causing it to disintegrate and thereby accelerating the dissolution of the active pharmaceutical ingredient (API).•Its level of use ranges from 0.5 to 5 percent, but 0.5 to 2 percent is sufficient in most formulations.•CCSisusedwithbindersasgreater the amount of binder in the tablet, the stronger it becomes. SigachiIndustries LimitedCSR Initiatives25•TheZillaParishadHigh-Sigachicontinuestopaypartsalaryofattendersandotherstaff,andalsosupportsstudentsbyprocuringstudymaterials.•CheersChildrenHome-Supportingstudentswiththeirschoolandcollegefees.•BirsaMundraHighSchool,Jharkhand–Helpedequiptheschoolwithbenchesanddesksforstudents.Wealsosupportedtoprovideforpuredrinkingwaterfacilityandtoilets.•Celebrated“DaanUtsav–JoyofGivingWeek’anemployeeledvolunteeringactivitytosupportunderprivilegedchildrenandseniorcitizens.•EnvironmentDaywascelebratedinfullspiritacrosstheunitswhereSigachianspledgedtoworktowardsabetterandgreenerplanetbycontributingineverylittlewaythattheycan.•TreeplantationdrivewasorganizedontheoccasionofWorldEnvironmentDayatoursituatedinDahej.Educating The Less PrivilegedWelfareDevelopment Program•TheflagshipCSRinitiative“IntegratedDevelopmentProgram”inBharuch&NarmadaDistrict,Gujarataimsatimprovingnutrition,drinkingwater&hygieneconditions,sanitation,andaccesstorenewableenergyto1000+tribalhouseholds.•AlsofocusonimprovingEducation&Skilling,Healthcare,Nutrition,WomenEmpowerment,WaterManagement,SustainableSourcing,WasteManagementandCommunityDevelopment.Industry OverviewSigachiIndustries LimitedMCC Industry27•Microcrystalline Cellulose Market size was valued USD 1.14 Bn in 2022 and expected to reach at forecast to reach USD 2.05 Bn by CY 2031, growing at a CAGR of 6.7% during CY 23-31.•Increasing application of MCC in various industries is a major factor propelling growth of the global MCC market. For instance, MCC is used as stabilizer and anti-caking agent in beverages. It is also used as a cold and hot stabilizer, in frozen food, in order to improve the shelf life of the product.•MCC is widely used in pharmaceuticals, owing to its tasteless, odor less, and chemical inertness properties. Growth in worldwide MCC Market is the expanding pharmaceutical industry.•Among end-use industries, pharmaceutical segment accounted for a dominant share in the market, owing to high use of microcrystalline cellulose in pharmaceutical.•Furthermore, food and beverage segment is expected to exhibit a substantial growth in the global microcrystalline cellulose market over the forecast period. This is due to wide application of MCC in various food and beverages including desserts, frozen food, dairy products, and baked goods. it is also used as a fat replacer and helps maintain the food consistency.•In line with the global trend, pharmaceutical will be major growth segment followed by food & beverages and cosmetic for MCC Market in India.323338353369434462287303319337382406218230242256289308158167176186210224CY20CY21 (E)CY22 (P)CY23 (P)CY24 (P)CY25 (P)MCC Market -Region Wise (in USD Mn)EuropeNorth AmericaAsia PacificRest of World212630344347131315182225668101418333344CY20CY21 (E)CY22 (P)CY23 (P)CY24 (P)CY25 (P)MCC Market in India (USD Mn)PharmaceuticalsFood & BeverageCosmetics & Personal CareOthersSource: CARE Report –August 2021, Straits Research: Speciality Chemical ReportSigachiIndustries LimitedKey Growth Drivers28Pharmaceutical Industry:•The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact.•Medicine spending in India is projected to grow 9 -12% over the next five years, leading India to become one of the top 10 countries in terms of medicine spending.•Going forward, better growth in domestic sales would also depend on the ability of companies to align their product portfolio towards chronic therapies for diseases such as such as cardiovascular, anti-diabetes, anti-depressants and anti-cancers, which are on the rise.Food & Beverage Industry:•Increased affluence of the ever-growing working population with increase in disposable income, rising urbanization leading to changing lifestyles•Increase in consumption of fast growing F&B (Food and Beverage) segments during special occasions and celebrations. •Increase in tourism in India and international travel by Indians increased the interest of Indians in international food products.Cosmetic Industry:•With the improving purchasing power, demand for enhanced products and increasing image consciousness of the Indian clientele, many international brands are establishing footprints in India which will be a key factor aiding this growth.•Herbal cosmetics products are driving growth due to increasing adoption, and the segment alone is expected to grow at 15%.•Social media & favorable demographics are playing an important role in spreading awareness about cosmetics products and developing fashion consciousness, not only in metros but also in tier-1 & 2 cities.269505CY 21CY 27(P)Food & Beverage Market in India (USD Bn)1329CY20CY26 (P)Cosmetics Market Size (USD Bn)Source: Ibef, Maximizemarketresearch, Businesswire4265130CY21CY24 (P)CY30 (P)Indian Pharma Market (USD Bn)Financial OverviewSigachiIndustries LimitedHistorical Consolidated Financial Performance30Particulars (INR Mn)FY21FY22FY23Q1-FY24Operational Revenue1,9282,5033,020847Total Expenses1,5401,9722,433683EBITDA388531587164EBITDA Margin (%)20.12%21.21%19.43%19.36%Depreciation and amortisation 23296620Finance costs13124313Other Income33266716PBT385516545147Tax Expense8211610938PAT303400436109PAT Margin (%)15.72%15.98%14.43%12.87%Other Comprehensive Income1(6)1-Total Comprehensive Income304394437109Diluted EPS13.1315.4414.163.54SigachiIndustries LimitedHistorical Consolidated Balance Sheet31Particulars (INR Mn)FY20FY21FY22FY23EQUITY6469422,2772,683Equity Share Capital7777307307Other Equity5698651,9702,376NON-CURRENT LIABILITIES557076308a) Financial Liabilitiesi) Borrowings19191210ii) Lease Liability---231b) Provisions78915c) Deferred tax liabilities (net)29435552CURRENT LIABILITIES390322515747a) Financial Liabilitiesi) Borrowings270183332395ii) Lease Liabilities---41iii) Trade Payables7280106208iv) Other financial liabilities14769b) Other current liabilities33435994c) Provisions1912-TOTAL LIABILITIES4453925911,055TOTAL EQUITY AND LIABILITIES1,0911,3342,8683,738Particulars (INR Mn)FY20FY21FY22FY23NON-CURRENT ASSETS3714631,0691,964a) Property, plant and equipment312376527960b) Capital work-in-progress313797349c) Right of Use Assets---257c) Intangible assets4377d) Financial assetsi) Investments-222ii) Other Financial Assets1418351225e) Other non-current assets102785164CURRENT ASSETS7208711,7991,774a) Financial Assetsi) Trade Receivables276358601802ii) Cash and cash equivalents88159291137iii) Bank balances other than above1821403190iv) Other financial assets4610012869b) Other current assets132171110c) Inventories279212305466TOTAL ASSETS1,0911,3342,8683,738SigachiIndustries LimitedConsolidated Financial Highlights1,9282,5033,020847FY21FY22FY23Q1-FY24Operational Revenue (INR Mn) 38853158716420.12%21.21%19.43%19.36%FY21FY22FY23Q1-FY24EBIDTA (INR Mn) & EBITDA Margins (%) 30340043610915.72%15.98%14.43%12.87%FY21FY22FY23Q1-FY24PAT (INR Mn) & PAT Margins (%) 92117124FY21FY22FY23Cash Conversion Cycle (Days)32%18%16%39%22%19%FY21FY22FY23ROCE (%) and ROE(%)ROEROCE0.22-0.150.03FY21FY22FY23Net Debt to Equity (x)32SigachiIndustries LimitedCapital Market Information 3333Market Data (INR) as on 30th June, 2023Face Value 10.0CMP 309.752 Week H/L 359.0/220.0Market Cap (INR Mn)9,522.49Shares O/S (Mn)30.7Avg. Volume (‘000)220.19Promoters48%Public52%Shareholding Pattern as on 30thJune, 2023-30%-20%-10%0%10%20%30%Jul 22Aug 22Sep 22Oct 22Nov 22Dec 22Jan 23Feb 23Mar 23Apr 23May 23Jun 23Share Price PerformanceSENSEXSIGACHISigachiIndustries Limited34SigachiIndustriesLimited Disclaimer:Norepresentationorwarranty,expressorimplied,ismadeasto,andnorelianceshouldbeplacedonthefairness,accuracy,completenessorcorrectnessoftheinformationoropinionscontainedinthispresentation.Suchinformationandopinionsareinalleventsnotcurrentafterthedateofthispresentation.Certainstatementsmadeinthispresentationmaynotbebasedonhistoricalinformationorfactsandmaybe"forwardlookingstatements"basedonthecurrentlyheldbeliefsandassumptionsofthemanagementofSigachiIndustriesLimited(Sigachi),whichareexpressedingoodfaithandintheiropinionreasonable,includingthoserelatingtotheCompany’sgeneralbusinessplansandstrategy,itsfuturefinancialconditionandgrowthprospectsandfuturedevelopmentsinitsindustryanditscompetitiveandregulatoryenvironmentForward-lookingstatementsinvolveknownandunknownrisks,uncertaintiesandotherfactors,whichmaycausetheactualresults,financialcondition,performanceorachievementsoftheCompanyorindustryresultstodiffermateriallyfromtheresults,financialcondition,performanceorachievementsexpressedorimpliedbysuchforward-lookingstatements,includingfuturechangesordevelopmentsintheCompany’sbusiness,itscompetitiveenvironmentandpolitical,economic,legalandsocialconditions.Further,pastperformanceisnotnecessarilyindicativeoffutureresults.Giventheserisks,uncertaintiesandotherfactors,viewersofthispresentationarecautionednottoplaceunduerelianceontheseforward-lookingstatements.TheCompanydisclaimsanyobligationtoupdatetheseforward-lookingstatementstoreflectfutureeventsordevelopmentsThispresentationisforgeneralinformationpurposesonly,withoutregardtoanyspecificobjectives,financialsituationsorinformationalneedsofanyparticularperson.Thispresentationdoesnotconstituteanofferorinvitationtopurchaseorsubscribeforanysecuritiesinanyjurisdiction,includingtheUnitedStates.Nopartofitshouldformthebasisoforberelieduponinconnectionwithanyinvestmentdecisionoranycontractorcommitmenttopurchaseorsubscribeforanysecurities.NoneofoursecuritiesmaybeofferedorsoldintheUnitedStates,withoutregistrationundertheU.S.SecuritiesActof1933,asamended,orpursuanttoanexemptionfromregistrationtherefromThispresentationisconfidentialandmaynotbecopiedordisseminated,inwholeorinpart,andinanymannerValorem Advisors Disclaimer: Valorem Advisors is an Independent Investor Relations Management Service company. This Presentation has been prepared by Valorem Advisors based on information and data which the Company considers reliable, but Valorem Advisors and the Company makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this Presentation. This Presentation may not be all inclusive and may not contain all of the information that you may consider material. Any liability in respect of the contents of, or any omission from, this Presentation is expressly excluded. Valorem Advisors also hereby certifies that the directors or employees of Valorem Advisors do not own any stock in personal or company capacity of the Company under review DisclaimerFor further details, please feel free to contact our Investor Relations Representatives:Mr. Anuj SonpalValorem AdvisorsTel: +91-22-4903-9500Email: sigachi@valoremadvisors.com Thank You